The role of a proliferation-inducing ligand (APRIL) in the pathogenesis of rheumatoid arthritis

References

• Nell VP, Machold KP, Stamm TA, Eberl G, Heinzl H, Uffmann M, Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis 2005;64:1731–6.
   PubMed Web of Science ®Google Scholar
• Edelman J, Russell AS. A comparison of patients with seropositive and seronegative rheumatoid arthritis. Rheumatol Int 1983;3:47–8.
   PubMed Web of Science ®Google Scholar
• Im CH, Kang EH, Ryu HJ, Lee JH, Lee EY, Lee YJ, Anti-cyclic citrullinated peptide antibody is associated with radiographic erosion in rheumatoid arthritis independently of shared epitope status. Rheumatol Int 2009;29:251–6.
   PubMedGoogle Scholar
• Kuhn KA, Kulik L, Tomooka B, Braschler KJ, Arend WP, Robinson WH, Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 2006;116:961–73.
   PubMed Web of Science ®Google Scholar
• Porter D, Madhok R, Capell H. Non-Hodgkin’s lymphoma in rheumatoid arthritis. Ann Rheum Dis 1991;50:275–6.
   PubMed Web of Science ®Google Scholar
• Atzeni F, Doria A, Turiel M, Sarzi-Puttini P. What is the role of rituximab in the treatment of rheumatoid arthritis? Autoimmun Rev 2007;6:553–8.
   PubMed Web of Science ®Google Scholar
• He X, Zhong W, McCarthy TG, Weyand CM, Goronzy JJ. Increased responsiveness of rheumatoid factor-producing B cells in seronegative and seropositive rheumatoid arthritis. Arthritis Rheum 1996;39:1499–506.
   PubMedGoogle Scholar
• Hahne M, Kataoka T, Schröter M, Hofmann K, IrmLer M, Bodmer JL, . APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med 1998;6:1185–90.
   Google Scholar
• Stein JV, Lopez-Fraga M, Elustondo FA, Carvalho-Pinto CE, Rodriguez D, Gomez-Caro R, APRIL modulates B and T cell immunity. J Clin Invest 2002;109:1587–98.
   PubMed Web of Science ®Google Scholar
• Gabay C, Krenn V, Bosshard C, Seemayer CA, Chizzolini C, Huard B. Synovial tissues concentrate secreted APRIL. Arthritis Res Ther 2009;11:R144.
   Google Scholar
• Xiao Y, Motomura S, Podack ER. APRIL (TNFSF13) regulates collagen-induced arthritis, IL-17 production and Th2 response. Eur J Immunol 2008;38:3450–8.
   PubMed Web of Science ®Google Scholar
• Nagatani K, Itoh K, Nakajima K, Kuroki H, Katsuragawa Y, Mochizuki M, Rheumatoid arthritis fibroblast-like synoviocytes express BCMA and are stimulated by APRIL. Arthritis Rheum 2007;56:3554–63.
   PubMedGoogle Scholar
• Miao J, Zhang K, Lv M, Li Q, Zheng Z, Han Q, Circulating Th17 and Th1 cells expressing CD161 are associated with disease activity in rheumatoid arthritis. Scand J Rheumatol.Published online: 7 January 2014.doi: 10.3109/03009742.2013.846407.
   Google Scholar
• Krenn V, Morawietz L, Häupl T, Neidel J, Petersen I, König A. Grading of chronic synovitis – a histopathological grading system for molecular and diagnostic pathology. Pathol Res Pract 2002;5:317–25.
   Google Scholar
• Mackay F, Sierro F, Grey ST, Gordon TP. The BAFF/APRIL system: an important player in systemic rheumatic diseases. Curr Dir Autoimmun 2005;8:243–65.
   PubMedGoogle Scholar
• Tan SM, Xu D, Roschke V, Perry JW, Arkfeld DG, Ehresmann GR, Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum 2003;48:982–92.
   PubMed Web of Science ®Google Scholar
• Schwaller J, Schneider P, Mhawech-Fauceglia P, McKee T, Myit S, Matthes T, Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness. Blood 2007;109:331–8.
   PubMed Web of Science ®Google Scholar
• Greiner A, Plischke H, Kellner H, Gruber R. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Ann N Y Acad Sci 2005;1050:295–303.
   PubMedGoogle Scholar
• Geng Y, Zhou W, Zhang ZL. A comparative study on the diversity of clinical features between the seronegative and seropositive rheumatoid arthritis patients. Rheumatol Int 2012;32:3897–901.
   PubMedGoogle Scholar
• Fujinami M, Sato K, Kashiwazaki S, Aotsuka S. Comparable histological appearance of synovitis in seropositive and seronegative rheumatoid arthritis. Clin Exp Rheumatol 1997;15:11–17.
   PubMedGoogle Scholar
• van Oosterhout M, Bajema I, Levarht EW, Toes RE, Huizinga TW, van Laar JM. Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis. Arthritis Rheum 2008;58:53–60.
   PubMed Web of Science ®Google Scholar
• Sun X, Zhao J, Liu R, Jia R, Sun L, Li X, Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis. Scand J Rheumatol 2013;42:97–101.
   PubMed Web of Science ®Google Scholar
• Yoshida S, Arakawa F, Higuchi F, Ishibashi Y, Goto M, Sugita Y, Gene expression analysis of rheumatoid arthritis synovial lining regions by cDNA microarray combined with laser microdissection: up-regulation of inflammation-associated STAT1, IRF1, CXCL9, CXCL10, and CCL5. Scand J Rheumatol 2012;41:170–9.
   PubMed Web of Science ®Google Scholar
• Hatzoglou A, Roussel J, Bourgeade MF, Rogier E, Madry C, Inoue J, TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase. J Immunol 2000;165:1322–30.
   PubMed Web of Science ®Google Scholar
• Gortz B, Hayer S, Tuerck B, Zwerina J, Smolen JS, Schett G. Tumour necrosis factor activates the mitogen-activated protein kinases p38alpha and ERK in the synovial membrane in vivo. Arthritis Res Ther 2005;7:R1140–7.
   Google Scholar
• Geng Y, Zhang ZL. Comparative study on the level of B lymphocyte stimulator (BlyS) and frequency of lymphocytes between seronegative and seropositive rheumatoid arthritis patients. Int J Rheum Dis 2012;15:478–85.
   PubMedGoogle Scholar